CliffBio
small molecule

BETOPTIC S

BETAXOLOL HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyNovartis →See this company's full patent-cliff portfolio

Drug detail

Brand nameBETOPTIC S
Active ingredientBETAXOLOL HYDROCHLORIDE
StrengthEQ 0.25% BASE
Dosage formSUSPENSION/DROPS
RouteOPHTHALMIC
ModalitySmall molecule
FDA approvalDecember 1989
Marketing statusRX

More from Novartis

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.